Restrictive Cardiomyopathy, Endocardial Fibrosis, and Eosinophilic Endomyocarditis



Restrictive Cardiomyopathy, Endocardial Fibrosis, and Eosinophilic Endomyocarditis


Fabio R. Tavora, M.D., Ph.D.

Allen P. Burke, M.D.



Restrictive Heart Disease

Restrictive heart disease refers to hemodynamic cardiac alterations that result from increased stiffness of the ventricles (diastolic dysfunction) causing impaired ventricular filling with preserved systolic function. The decrease in ventricular compliance is secondary to infiltrative disease of the myocardium (most frequently amyloid), endocardial disease, or nonischemic cardiomyopathy.

“Idiopathic” restrictive cardiomyopathy generally denotes today a form of nonischemic cardiomyopathy that may overlap genetically and clinically with dilated cardiomyopathy (see Chapter 19) but is marked primarily by restrictive hemodynamics. Primary acquired endocardial disease in adults is generally classified as tropical (idiopathic endocardial fibrosis) or eosinophilic. Congenital endocardial fibrosis is considered a form of infantile dilated cardiomyopathy (see Chapter 23).


Hemodynamic Findings

Because of increased ventricular stiffness, there is reduced diastolic ventricular volume with normal or near-normal systolic function (ejection fraction) and wall thickness. Ventricular pressures rise markedly with small increases in volume, and left ventricular end-diastolic volume is <100 mL/m2 with pressures >18 mm Hg. The atria are dilated with nonhypertrophied, nondilated ventricles. Pressure tracings show a characteristic diastolic dip and a plateau or a square root sign. Atrial fibrillation is noted in three-fourths of patients.1


Idiopathic Restrictive Cardiomyopathy


Genetic Findings

Patients with familial restrictive cardiomyopathy have familial phenotypes and genetic alterations that reflect hypertrophic, dilated, and noncompaction-type cardiomyopathy. One-third have sarcomere protein gene mutations involving cardiac troponin I gene (TNNI3), troponin T (TNNT2) desmin (DES), and alpha-cardiac actin (ACTC).2,3 Recently, mutations in TNNI3 (cardiac troponin I type 3) have been described in children with restrictive cardiomyopathy.4,5

Restrictive cardiomyopathy may be a manifestation of the myofibrillar myopathies, which are characterized by disintegration of the Z-disk, accumulation of cytoplasmic myofibrillar osmiophilic bodies ultrastructurally, and sometimes congophilic material on skeletal muscle biopsies. Myofibrillar myopathies may also manifest as arrhythmogenic and dilated cardiomyopathy.6 Mutations involved in myofibrillar myopathies include desmin, αB-crystallin, myotilin, ZASP, filamin C, and BAG3. Of these, desmin, αB-crystallin, and BAG3 have been implicated in cardiomyopathy.7







FIGURE 162.1 ▲ Restrictive cardiomyopathy. An autopsy heart from a child with idiopathic restrictive cardiomyopathy. Note relatively normal-appearing ventricles and marked dilatation of atria.


Gross Pathologic Findings

Grossly, the ventricles are relatively normal, but there is marked biatrial dilatation (Fig. 162.1).


Histologic Findings

The histologic features of idiopathic restrictive cardiomyopathy are nonspecific, including interstitial fibrosis and myocyte hypertrophy. Most cases with histologic evaluation have demonstrated myofiber disarray, but in the absence of significant hypertrophy.8

A subset of restrictive cardiomyopathy is associated with intramyocyte desmin deposition (desminopathy, a form of myofibrillar myopathy) involving the heart and skeletal muscle. Atrioventricular block is common. Electron microscopy is necessary to demonstrate filamentous desmin deposits9,10.


Idiopathic Endomyocardial Fibrosis


Clinical Findings

Idiopathic endomyocardial fibrosis is a disorder of the tropical and subtropical regions that is clinically characterized by restrictive cardiomyopathy. The eponym term “Davies disease” has been used because of descriptions of the disease by Davies in the 1950s and 1960s in Africa.11,12,13,14 It affects predominantly children and young adults.15 The disease is endemic in India and South America, as well as Africa.16 It is rare in the United States.

In contrast to eosinophilic endomyocarditis, most patients do not have peripheral eosinophilia. Ventriculograms demonstrate changes in ventricular morphology with restriction or obliteration in the inflow tract or apex, reduction in the diastolic ventricular dimension, endocardial irregularities, and, in severe cases, a tubular distortion of the ventricle due to obliteration of the inflow tract. Mitral and tricuspid regurgitation are typical. Magnetic resonance imaging findings include ventricular diastolic dysfunction, systolic dysfunction, and extensive subendocardial delayed contrast enhancement with atrial enlargement and organized ventricular thrombus.17 Surgical treatment includes valve replacement or repair, and resection of the endocardial fibrotic tissue.16 In instances, surgical treatment is curative. Even though bilateral disease is typical, there may be isolated left or right ventricular involvement.15

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 19, 2016 | Posted by in CARDIOLOGY | Comments Off on Restrictive Cardiomyopathy, Endocardial Fibrosis, and Eosinophilic Endomyocarditis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access